Answers are grounded in this paper and cite their sources.
Case report reveals neurotoxicity in a Maine Coon cat homozygous for a genetic variant affecting drug metabolism, suggesting need for better screening.
Case Summary A nine-month-old male-neutered Maine Coon cat developed tongue protrusion, mydriasis, generalised weakness and ataxia following routine application of NexGard Spectra□ (Boehringer Ingelheim, Animal Health Australia, North Ryde, Sydney, Australia; active ingredients praziquantel 83g/L; esafoxolaner 12g/L; eprinomectin 4g/L). The cat was managed conservatively for suspected macrocyclic lactone toxicity and made a complete recovery over three months. Further testing identified the cat was homozygous for ABCB11930_1931del TC, a recently identified variant for encoding for the drug transporter molecule P-glycoprotein (P-gp). Cats who are homozygous for ABCB11930_1931del TC have a non-functional P-gp. Due to this change, affected cats have an increased risk of neurotoxicity of macrocyclic lactone and other P-gp substrate drugs, as seen in this case. Relevance and Novel information This is the first documented case of a cat homozygous for ABCB11930_1931del TC in Australia with macrocyclic lactone toxicity following administration of an eprinomectin containing product at label doses. Further awareness of this genetic variant and implications in use of substrate drugs, including new generation macrocyclic lactones, are required to improve safety of these products in the general cat population. This includes the development and promotion of commercially available screening tests to facilitate personalised treatment advice.
No takes yet. Share an insight, caveat, or question.
Madeleine Roberts (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: